Ellen Rosenberg

Track

Insider profile

Currently holds a position at Amicus Therapeutics Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 58% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
General Counsel, Corporate Secretary, Chief Legal Officer Amicus Therapeutics Inc Dec. 1, 2018 -
General Counsel and Corporate Secretary Amicus Therapeutics Inc Feb. 8, 2016 - Dec. 1, 2018
Ellen Rosenberg's trades of Amicus Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
489.04
Quantity 20,566
Value US$2,370,690
Transaction date
Sale
Price
295.45
Quantity 83,552 +9.9%
Value US$12,915
Transaction date
Sale
Price
487.84
Quantity 66,355 +3.9%
Value US$1,219,863
Transaction date
Proposed sale
Price
9.89
Quantity 36,000
Value US$356,040
Transaction date
Proposed sale
Price
9.56
Quantity 36,000
Value US$344,160
Transaction date
Sale
Price
13.00
Quantity 400 -0.1%
Value US$5,200
Transaction date
Proposed sale
Price
12.70
Quantity 30,000
Value US$381,000
Transaction date
Proposed sale
Price
14.19
Quantity 30,000
Value US$425,700
Transaction date
Proposed sale
Price
13.60
Quantity 35,000
Value US$476,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-26 2025-11-26
PrS Proposed sale
20,566
489.04
US$2,370,690 		20,566 489.04 US$2,370,690
2025-11-26 2025-11-26
S Sale
83,552 +9.9%
295.45
US$12,915 		83,552 +9.9% 295.45 US$12,915
2025-11-26 2025-11-25
S Sale
66,355 +3.9%
487.84
US$1,219,863 		66,355 +3.9% 487.84 US$1,219,863
2025-11-25 2025-11-25
PrS Proposed sale
36,000
9.89
US$356,040 		36,000 9.89 US$356,040
2025-11-26 2025-11-24
S Sale
36,000 -6.6%
10.06
US$362,268 		36,000 -6.6% 10.06 US$362,268
2025-11-24 2025-11-24
PrS Proposed sale
36,000
9.56
US$344,160 		36,000 9.56 US$344,160
2024-02-08 2024-02-07
S Sale
29,600 -7.5%
13.00
US$384,818 		29,600 -7.5% 13.00 US$384,818
2024-02-08 2024-02-06
S Sale
400 -0.1%
13.00
US$5,200 		400 -0.1% 13.00 US$5,200
2024-02-06 2024-02-06
PrS Proposed sale
30,000
12.70
US$381,000 		30,000 12.70 US$381,000
2024-01-04 2024-01-02
S Sale
30,000 -8.1%
14.21
US$426,219 		30,000 -8.1% 14.21 US$426,219
2024-01-02 2024-01-02
PrS Proposed sale
30,000
14.19
US$425,700 		30,000 14.19 US$425,700
2023-12-28 2023-12-27
S Sale
5,000 -1.4%
14.07
US$70,327 		5,000 -1.4% 14.07 US$70,327
2023-12-28 2023-12-26
S Sale
30,000 -8.1%
14.00
US$420,084 		30,000 -8.1% 14.00 US$420,084
2023-12-26 2023-12-26
PrS Proposed sale
35,000
13.60
US$476,000 		35,000 13.60 US$476,000
2023-01-25 2023-01-24
PlS Planned sale
31,839 -8.7%
13.32
US$424,006 		31,839 -8.7% 13.32 US$424,006
2022-08-03 2022-08-01
PlS Planned sale
11,123 -3.8%
10.02
US$111,472 		11,123 -3.8% 10.02 US$111,472
2022-06-22 2022-06-21
PlS Planned sale
11,122 -3.7%
10.00
US$111,272 		11,122 -3.7% 10.00 US$111,272
2022-04-08 2022-04-07
PlS Planned sale
11,018 -3.5%
9.06
US$99,797 		11,018 -3.5% 9.06 US$99,797
2020-07-20 2020-07-16
PlS Planned sale
30,000 -13.3%
15.26
US$457,911 		30,000 -13.3% 15.26 US$457,911
2020-01-17 2020-01-15
PlS Planned sale
22,100 -10.7%
10.35
US$228,642 		22,100 -10.7% 10.35 US$228,642
2020-01-03 2020-01-02
PlS Planned sale
10,448 -4.9%
9.56
US$99,884 		10,448 -4.9% 9.56 US$99,884